ArticleAIDS research and therapy2010

Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.

Luis F López-Cortés et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.